Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort

OBJECTIVE: The first-line treatment for Cushing’s disease is transsphenoidal surgery, after which the rates of remission are 60 to 80%, with long-term recurrence of 20 to 30%, even in those with real initial remission. Drug therapies are indicated for patients without initial remission or with surgi...

Descripción completa

Detalles Bibliográficos
Autores principales: Viecceli, Camila, Mattos, Ana Carolina Viana, Costa, Maria Carolina Bittencourt, de Melo, Rafael Borba, Rodrigues, Ticiana da Costa, Czepielewski, Mauro Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585352/
https://www.ncbi.nlm.nih.gov/pubmed/36277689
http://dx.doi.org/10.3389/fendo.2022.1017331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585352/
https://www.ncbi.nlm.nih.gov/pubmed/36277689
http://dx.doi.org/10.3389/fendo.2022.1017331

Ejemplares similares